Pfizer's Top-Selling Lipitor

Pfizer's Top-Selling Lipitor

JB Reed/Bloomberg

Pfizer is counting on revenue from tasocitinib to help offset losses when its top-selling Lipitor cholesterol pill, seen here, faces competition next year from cheaper copies in the U.S.